Most commonly used in the treatment of chronic or life threatening conditions such as rheumatoid arthritis and cancer, specialty drugs represent the fastest growing sector of pharmacy spending today. Although specialty medications currently account for only 1% of all prescriptions, they represent about 20% of today's drug costs. Industry experts predict that by 2020, specialty drug spend will more than quadruple, reaching approximately $402 billion a year and presenting tremendous cost challenges for employers.
News from the National Alliance, member coalitions, partners, and industry to help drive quality and value of healthcare services.
Thursday, January 9, 2014
New NBCH Action Brief: Specialty Pharmacy
NBCH is pleased to continue this series of Action Briefs developed to support the critical role purchasers and purchaser-led coalitions play as change agents in improving health and health care in employee populations and the community at large. Each Action Brief centers on a specific topic of interest highlighting why employers should care; using eValue8™ data to better explain the role of health plans around the issue; and providing action steps and strategies employers can take to improve health and health care delivery.
View the newest Action Brief - January 2014: Specialty Pharmacy
Most commonly used in the treatment of chronic or life threatening conditions such as rheumatoid arthritis and cancer, specialty drugs represent the fastest growing sector of pharmacy spending today. Although specialty medications currently account for only 1% of all prescriptions, they represent about 20% of today's drug costs. Industry experts predict that by 2020, specialty drug spend will more than quadruple, reaching approximately $402 billion a year and presenting tremendous cost challenges for employers.
Check out the whole series of briefs archived at Publications-NBCH Action Briefs.
Most commonly used in the treatment of chronic or life threatening conditions such as rheumatoid arthritis and cancer, specialty drugs represent the fastest growing sector of pharmacy spending today. Although specialty medications currently account for only 1% of all prescriptions, they represent about 20% of today's drug costs. Industry experts predict that by 2020, specialty drug spend will more than quadruple, reaching approximately $402 billion a year and presenting tremendous cost challenges for employers.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment